Based on our previously obtained results on colorectal cancer, we hypothesized that selected polymorphisms in TLR5 gene could be associated with COPD and/or LC predisposition and potentially recognized as yet unknown biomarker of LC development in the patients diagnosed with COPD. This evidence concerns the gene TLR5 and chronic obstructive pulmonary disease.